Suppr超能文献

麻醉期间发生的过敏反应。

Allergic reactions occurring during anaesthesia.

作者信息

Mertes P M, Laxenaire M C

机构信息

CHU de Nancy, Hĵpital Central, Département d'Anesthésie-réanimation, France.

出版信息

Eur J Anaesthesiol. 2002 Apr;19(4):240-62. doi: 10.1017/s0265021502000418.

Abstract

Anaphylactic reactions to anaesthetic and associated agents used during the perioperative period have been reported with increasing frequency in most developed countries. Any drug administered in the perioperative period can potentially produce life-threatening immune-mediated anaphylaxis. Most published reports on the incidence of anaphylaxis come from France, Australia, the UK and New Zealand. These reflect an active policy of systematic clinical and/or laboratory investigation of suspected immune-mediated reactions. The estimated incidence of anaphylaxis ranges from 1:10,000 to 1:20,000. Muscle relaxants (69.1%) and latex (12.1%) were the most frequently involved drugs according to the most recent French epidemiological survey. Clinical symptoms do not afford an easy distinction between immune-mediated anaphylactic reactions and anaphylactoid reactions resulting from direct non-specific histamine release. Moreover, when restricted to a single clinical symptom, anaphylaxis can easily be misdiagnosed. Pre- and postoperative investigation must be performed to confirm the nature of the reaction, the responsibility of the suspected drugs and to provide precise recommendations for future anaesthetic procedures. These include plasma histamine, tryptase and specific IgE concentration determination at the time of the reaction and at skin tests 6 weeks later. In addition, since no specific treatment has been shown reliably to prevent the occurrence of anaphylaxis, allergy assessment must be performed in all high-risk patients. Treatment of anaphylaxis is aimed at interrupting contact with the responsible antigen, inhibiting mediator production and release, and modulating the effects of released mediators. It must be initiated as quickly as possible and relies on widely accepted principles. Finally, the need for proper epidemiological studies and the relative complexity of allergy investigation should be underscored. They represent an incentive for further development of allergo-anaesthesiology clinical networks to provide expert advice for anaesthetists and allergologists.

摘要

在大多数发达国家,围手术期使用麻醉剂及相关药物引起的过敏反应报告频率越来越高。围手术期使用的任何药物都有可能引发危及生命的免疫介导过敏反应。大多数关于过敏反应发生率的已发表报告来自法国、澳大利亚、英国和新西兰。这些报告反映了对疑似免疫介导反应进行系统临床和/或实验室调查的积极政策。过敏反应的估计发生率在1:10,000至1:20,000之间。根据法国最新的流行病学调查,肌肉松弛剂(69.1%)和乳胶(12.1%)是最常涉及的药物。临床症状难以区分免疫介导的过敏反应和直接非特异性组胺释放引起的类过敏反应。此外,仅依据单一临床症状时,过敏反应很容易被误诊。必须进行术前和术后调查,以确认反应的性质、疑似药物的责任,并为未来的麻醉程序提供精确建议。这些调查包括在反应发生时以及6周后进行皮肤试验时测定血浆组胺、类胰蛋白酶和特异性IgE浓度。此外,由于尚未证明有任何特异性治疗能可靠地预防过敏反应的发生,因此必须对所有高危患者进行过敏评估。过敏反应的治疗旨在中断与致病抗原的接触、抑制介质的产生和释放,并调节已释放介质的作用。治疗必须尽快开始,并依赖广泛接受的原则。最后,应强调进行适当流行病学研究的必要性以及过敏调查的相对复杂性。它们促使进一步发展过敏麻醉临床网络,为麻醉师和过敏症专科医生提供专家建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验